Top ▲
Target id: 1506
Nomenclature: CDC42 binding protein kinase gamma
Abbreviated Name: DMPK2
Family: GEK subfamily
Gene and Protein Information ![]() |
||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | - | 1551 | 11q13.1 | CDC42BPG | CDC42 binding protein kinase gamma | |
Mouse | - | 1551 | 19 A | Cdc42bpg | CDC42 binding protein kinase gamma | |
Rat | - | 1551 | 1q43 | Cdc42bpg | CDC42 binding protein kinase gamma |
Database Links ![]() |
|
Alphafold | Q6DT37 (Hs), Q80UW5 (Mm) |
BRENDA | 2.7.11.1 |
CATH/Gene3D | 2.30.29.30 |
ChEMBL Target | CHEMBL5615 (Hs) |
Ensembl Gene | ENSG00000171219 (Hs), ENSMUSG00000024769 (Mm), ENSRNOG00000027456 (Rn) |
Entrez Gene | 55561 (Hs), 240505 (Mm), 293693 (Rn) |
Human Protein Atlas | ENSG00000171219 (Hs) |
KEGG Enzyme | 2.7.11.1 |
KEGG Gene | hsa:55561 (Hs), mmu:240505 (Mm), rno:293693 (Rn) |
OMIM | 613991 (Hs) |
Pharos | Q6DT37 (Hs) |
RefSeq Nucleotide | NM_017525 (Hs), XM_140553 (Mm), NM_001130013 (Rn) |
RefSeq Protein | NP_059995 (Hs), NP_001028514 (Mm), NP_001123485 (Rn) |
UniProtKB | Q6DT37 (Hs), Q80UW5 (Mm) |
Wikipedia | CDC42BPG (Hs) |
Enzyme Reaction ![]() |
||||
|
DiscoveRx KINOMEscan® screen ![]() |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A screen of 72 inhibitors against 456 human kinases. Quantitative data were derived using DiscoveRx KINOMEscan® platform. http://www.discoverx.com/services/drug-discovery-development-services/kinase-profiling/kinomescan Reference: 1-2 |
![]() ![]() |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Target used in screen: DMPK2 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Displaying the top 10 most potent ligands View all ligands in screen » |
1. Davis MI, Hunt JP, Herrgard S, Ciceri P, Wodicka LM, Pallares G, Hocker M, Treiber DK, Zarrinkar PP. (2011) Comprehensive analysis of kinase inhibitor selectivity. Nat Biotechnol, 29 (11): 1046-51. [PMID:22037378]
2. Wodicka LM, Ciceri P, Davis MI, Hunt JP, Floyd M, Salerno S, Hua XH, Ford JM, Armstrong RC, Zarrinkar PP et al.. (2010) Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry. Chem Biol, 17 (11): 1241-9. [PMID:21095574]
GEK subfamily: CDC42 binding protein kinase gamma. Last modified on 29/01/2016. Accessed on 25/04/2025. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetomalariapharmacology.org/GRAC/ObjectDisplayForward?objectId=1506.